Markosyan and his colleagues identified PTGS2 was upregulated by EPHA2, a candidate tumor intrinsic driver of immunosuppression, through TGF-β pathway in pancreatic cancer (18). The gene discussed is EPHA2; the disease is familial pancreatic carcinoma.